Page last updated: 2024-10-27

fenofibrate and Cardiomyopathy, Hypertrophic Obstructive

fenofibrate has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asai, T1
Okumura, K1
Takahashi, R1
Matsui, H1
Numaguchi, Y1
Murakami, H1
Murakami, R1
Murohara, T1

Other Studies

1 other study available for fenofibrate and Cardiomyopathy, Hypertrophic Obstructive

ArticleYear
Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.
    Cardiovascular research, 2006, Jun-01, Volume: 70, Issue:3

    Topics: Adenosine Triphosphate; Animals; Cardiomyopathy, Hypertrophic; Carnitine; Diglycerides; Drug Therapy

2006